ArticleBMC medical ethics2019
Research approvals iceberg: how a 'low-key' study in England needed 89 professionals to approve it and how we can do better.
Article in BMC medical ethics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Maximising inclusivity in care home research: Lessons learned from the AFRI-c randomised controlled trial.The Journal of frailty & aging · 2025Trial
- Research governance in England needs improvements to ensure participant and site confidentiality in healthcare workforce research.Health research policy and systems · 2026Article
- Ethics review or compliance check? an empirical analysis of 6740 requests for information in Belgian clinical trial evaluations (2017-2024).BMC medical ethics · 2025Article
- Global comparison of research ethical review protocols: insights from an international research collaborative.BJU international · 2025Article
- Fitting a square peg in a round hole? A mixed-methods study on research ethics and collaborative health and social care research involving 'vulnerable' groups.Health research policy and systems · 2025Article
- Article
- Why are organisational approvals needed for low-risk staff studies in the UK? Procedures, barriers, and burdens.BMC health services research · 2024Article
- Article
- Ranking Research Methodology by Risk - a cross-sectional study to determine the opinion of research ethics committee members.Systematic reviews · 2023Article
- Institutional review boards in Saudi Arabia: the first survey-based report on their functions and operations.BMC medical ethics · 2023Article
- Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions.Trials · 2023Article
- Article
- Evidence from UK Research Ethics Committee members on what makes a good research ethics review, and what can be improved.PloS one · 2023Article
- Protecting the public from the adverse effects of confused research ethics.Journal of the Royal Society of Medicine · 2021Article
- Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands.Health research policy and systems · 2020Article
- Article
- Research approvals iceberg: helping it melt away.BMC medical ethics · 2019Article
- Response to Correspondence from Kolstoe and colleagues concerning our paper entitled, Research approvals iceberg: How a 'low-key' study in England needed 89 professionals to approve it and how we can do better.BMC medical ethics · 2019Article
- 'It Shouldn't Be This Hard': Exploring the Challenges of Rural Health Research.International journal of environmental research and public health · 2019Article
- Lessons from studies of medication reduction in psychosis: giving participants accurate information about risk in psychiatric research trials.Journal of psychiatry & neuroscience : JPNArticle
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe red tape and delays around research ethics and governance approvals frequently frustrate researchers yet, as the lesser of two evils, are largely accepted as unavoidable. Here we quantify aspects of the research ethics and governance approvals for one interview- and questionnaire-based study conducted in England which used the National Health Service (NHS) procedures and the electronic Integrated Research Application System (IRAS). We demonstrate the enormous impact of existing approvals processes on costs of studies, including opportunity costs to focus on the substantive research, and suggest directions for radical system change. MAIN TEXT: We have recorded 491 exchanges with 89 individuals involved in research ethics and governance approvals, generating 193 pages of email text excluding attachments. These are conservative estimates (e.g. only records of the research associate were used). The exchanges were conducted outside IRAS, expected to be the platform where all necessary documents are provided and questions addressed. Importantly, the figures exclude the actual work of preparing the ethics documentation (such as the ethics application, information sheets and consent forms). We propose six areas of work to enable system change: 1. Support the development of a broad range of customised research ethics and governance templates to complement generic, typically clinical trials orientated, ones; 2. Develop more sophisticated and flexible frameworks for study classification; 3. Link with associated processes for assessment, feedback, monitoring and reporting, such as ones involving funders and patient and public involvement groups; 4. Invest in a new generation IT infrastructure; 5. Enhance system capacity through increasing online reviewer participation and training; and 6. Encourage researchers to quantify the approvals processes for their studies.
conclusionEthics and governance approvals are burdensome for historical reasons and not because of the nature of the task. There are many opportunities to improve their efficiency and analytic depth in an age of innovation, increased connectivity and distributed working. If we continue to work under current systems, we are perpetuating, paradoxically, an unethical system of research approvals by virtue of its wastefulness and impoverished ethical debate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.